Navigation Links
Vermillion Reports Results for the Second Quarter 2011
Date:8/4/2011

nts. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty as to Vermillion's ability to protect and promote its proprietary technology; (2) Vermillion's lack of a lengthy track record successfully developing and commercializing diagnostic products; (3) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its future diagnostic products; (4) uncertainty of the size of market for its existing diagnostic tests or future diagnostic products, including the risk that its products will not be competitive with products offered by other companies, or that patients will not be able to receive reimbursement for Vermillion's tests from third party payors such as private insurance companies and government insurance plans; (5) uncertainty whether Vermillion will successfully license or otherwise successfully partner with third parties to commercialize its future products; (6) uncertainty whether the trading in Vermillion's stock will become significantly less liquid or more volatile; and (7) other factors that might be described from time to time in Vermillion's filings with the Securities and Exchange Commission. All information in this press release is as of the date of this report, and Vermillion expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Vermillion's expectations or any change in events, conditions or circumstances on which any such statement is based, unless required by law.  

This release should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent reports on Form 10-K and Form 10-Q.  Copies are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR) at www.sec.gov.Vermillion, Inc.Consolidated Balance Sheets(Amounts in Thousands,
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Vermillion and Stanford Scientists Receive Best Research Award From the PAD Coalition
2. Vermillion Announces Receipt of NASDAQ Panel Decision
3. Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
4. Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code
5. Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors
6. Vermillion Announces Return of Eric Fung, M.D., Ph.D.
7. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
8. Vermillion to Attend Society of Gynecologic Oncologists Meeting March 15-19
9. Vermillion Announces Issuance of European Patent
10. Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
11. Stephens Initiates Coverage on Vermillion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... August 27, 2014 Flagship Biosciences LLC, ... services to the pharmaceutical and medical device industries, has ... The fast growing company has consolidated its histology and ... Boulder to Westminster, CO, just north of Denver. ... 7575 W. 103rd Ave., Suite 100, Westminster, CO 80021 ...
(Date:8/27/2014)... , Aug. 27, 2014 Research and ... "Global Enzyme for Pulp & Paper Industry Report 2014" ... Global Enzyme for Pulp & Paper Industry Report 2014 ... state of the global enzyme for pulp & paper ... of the industry including definitions, classifications, applications and industry ...
(Date:8/27/2014)... Aug. 27, 2014 Research and Markets ... Isotope Ratio Mass Spectrometer Industry Report 2014" report ... Isotope Ratio Mass Spectrometer Industry Report 2014 is a ... the global isotope ratio mass spectrometer industry. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:8/27/2014)... -- ARCH Venture Partners, one of the largest U.S. ... seed and early-stage advanced technology companies, today announced ... than $400 million in subscriptions. ARCH Venture Fund ... more than $150 million. "The enthusiasm ... of our approach to finding and funding new ...
Breaking Biology Technology:Flagship Biosciences Announces Relocation and Expansion 2Global Enzyme for Pulp & Paper Industry Report 2014 2Global Stable Isotope Ratio Mass Spectrometer Industry Report 2014 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3
... China, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Biologic,Products, Inc. ... of the leading plasma-based pharmaceutical companies in the,People,s ... for,the third quarter ended September 30, 2008., ... increased 54.4% year-over-year to $13.8 million -- ...
... 12 Telik, Inc.,(Nasdaq: TELK ) announced ... technology to investigators at the Hospital for Special ... mechanisms underlying,musculoskeletal and autoimmune diseases to discover effective ... TRAP technology to,discover novel compounds that inhibit a ...
... SpineSmith Partners, an,innovative bio-medical device company, is ... University of Texas Biomedical Engineering Department,to help ... commercialization,process of medical devices., Photo: ... engineering students will work closely with,SpineSmith,s product ...
Cached Biology Technology:China Biologic Products Reports Strong Third Quarter 2008 Results 2China Biologic Products Reports Strong Third Quarter 2008 Results 3China Biologic Products Reports Strong Third Quarter 2008 Results 4China Biologic Products Reports Strong Third Quarter 2008 Results 5China Biologic Products Reports Strong Third Quarter 2008 Results 6China Biologic Products Reports Strong Third Quarter 2008 Results 7China Biologic Products Reports Strong Third Quarter 2008 Results 8China Biologic Products Reports Strong Third Quarter 2008 Results 9China Biologic Products Reports Strong Third Quarter 2008 Results 10China Biologic Products Reports Strong Third Quarter 2008 Results 11China Biologic Products Reports Strong Third Quarter 2008 Results 12China Biologic Products Reports Strong Third Quarter 2008 Results 13China Biologic Products Reports Strong Third Quarter 2008 Results 14China Biologic Products Reports Strong Third Quarter 2008 Results 15China Biologic Products Reports Strong Third Quarter 2008 Results 16Telik Announces New TRAP Drug Discovery Agreement 2SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products 2
(Date:8/27/2014)... North Carolina State University have found that century-old museum specimens ... common insect pest that can weaken and kill trees ... that scale insect populations increase on oak and maple trees ... pests may also increase with global warming," says Dr. Elsa ... of a paper on the work. , "More scale insects ...
(Date:8/26/2014)... University in St. Louis have developed algorithms to identify ... tearing or breaking. The technology, which needs to be ... may help pinpoint minor strains and tiny injuries in ... The research is available online Aug. 27 in the ... publishes research at the nexus of the physical and ...
(Date:8/26/2014)... colony of harmful bacteria, biofilms make the treatment ... a biofilm pose a significant health risk due ... and biofilm-protected bacteria account for some 80 percent ... 50 to 1,000 times more resistant to antibiotics ... may have stumbled onto a magic bullet," said ...
Breaking Biology News(10 mins):Museum specimens, modern cities show how an insect pest will respond to climate change 2New technology may identify tiny strains in body tissues before injuries occur 2New technology may identify tiny strains in body tissues before injuries occur 3Breakthrough antibacterial approach could resolve serious skin infections 2Breakthrough antibacterial approach could resolve serious skin infections 3
... biomechanics and physiology from six universities, led by ... Technologys Media Lab, refute scientific claims that the ... African bilateral amputee track athlete, provide him with ... conclusions were based on data collected at the ...
... a simple artificial cell with which to investigate the organization ... the cell membrane and the cytoplasm--the gelatinous fluid that surrounds ... to the creation of new drugs that take advantage of ... The team,s findings will be published later this month ...
... CAMBRIDGE, Mass.--MIT engineers have improved the power output ... than 50 percent through technology that could help ... much broader market, particularly in portable electronics. ... also considerably less expensive than its conventional industrial ...
Cached Biology News:Breaking news: Study revives Olympic prospects for amputee sprinter 2Breaking news: Study revives Olympic prospects for amputee sprinter 3Simple model cell is key to understanding cell complexity 2MIT creates new material for fuel cells 2MIT creates new material for fuel cells 3
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
EGTA, 10 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
GOAT ANTI FRK...
UV LAMP 300 NM 8W T5, 1 EA. Category: Nucleid Acid Detection Systems....
Biology Products: